HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas M Magin Selected Research

Keratin-5 (Keratin 5)

1/2020Disease-associated keratin mutations reduce traction forces and compromise adhesion and collective migration.
6/2019Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders.
1/2018Threonine 150 Phosphorylation of Keratin 5 Is Linked to Epidermolysis Bullosa Simplex and Regulates Filament Assembly and Cell Viability.
10/2015Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.
8/2015A Drosophila Model of Epidermolysis Bullosa Simplex.
3/2006Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas M Magin Research Topics

Disease

10Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
12/2022 - 01/2007
7Inflammation (Inflammations)
06/2019 - 12/2007
7Neoplasms (Cancer)
01/2019 - 11/2004
3Neoplasm Metastasis (Metastasis)
02/2015 - 01/2013
2Epidermolysis Bullosa
06/2019 - 06/2015
2Infections
01/2019 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2015 - 07/2002
2Cataract (Cataracts)
03/2009 - 11/2008
2Dowling-Degos Disease
12/2007 - 03/2006
2Hyperpigmentation
12/2007 - 03/2006
2Liver Diseases (Liver Disease)
08/2007 - 05/2006
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022
1Systemic Mastocytosis
12/2022
1Wounds and Injuries (Trauma)
11/2020
1Dysostoses
01/2020
1Premature Aging
01/2020
1Liver Neoplasms (Liver Cancer)
02/2019
1Carcinogenesis
01/2019
1Contagious Ecthyma
01/2019
1Skin Diseases (Skin Disease)
01/2018
1Pemphigus (Pemphigus Vulgaris)
01/2018
1Fibrosis (Cirrhosis)
08/2015
1Cardiomyopathies (Cardiomyopathy)
08/2015
1Necrosis
08/2015
1Melanoma (Melanoma, Malignant)
05/2014
1Adenocarcinoma
01/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Cystic Fibrosis (Mucoviscidosis)
11/2012
1Inborn Genetic Diseases (Disease, Hereditary)
10/2012
1Body Weight (Weight, Body)
06/2012
1Porphyrias (Porphyria)
06/2012
1Spontaneous Abortion (Miscarriage)
04/2011
1Hyperoxia
04/2011
1Hypoxia (Hypoxemia)
04/2011
1Proteostasis Deficiencies
04/2010
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
09/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2006
1Chronic Pancreatitis
05/2006
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2006
1End Stage Liver Disease
05/2006
1Alexander Disease (Alexander's Disease)
01/2006
1Glioma (Gliomas)
12/2005
1Neuroblastoma
12/2005
1Tetraploidy
03/2005
1Papilloma (Papillomatosis)
11/2004

Drug/Important Bio-Agent (IBA)

26Keratins (Keratin)IBA
12/2022 - 07/2002
6Keratin-5 (Keratin 5)IBA
01/2020 - 03/2006
6Proteins (Proteins, Gene)FDA Link
10/2015 - 11/2004
4VimentinIBA
01/2020 - 11/2008
4Keratin-14 (Keratin 14)IBA
01/2020 - 08/2015
3K-18 conjugate (K18)IBA
11/2012 - 05/2006
2Protein AggregatesIBA
06/2019 - 11/2008
2DesmogleinsIBA
01/2018 - 08/2015
2Mitogen-Activated Protein KinasesIBA
05/2014 - 11/2004
2CytokinesIBA
09/2009 - 05/2009
2AntibodiesIBA
09/2009 - 08/2006
1midostaurinIBA
12/2022
1Phosphotransferases (Kinase)IBA
12/2022
14-phenylbutyric acid (Buphenyl)FDA Link
06/2019
1Keratin-8 (Keratin 8)IBA
02/2019
1Viral ProteinsIBA
01/2019
1Cell Adhesion MoleculesIBA
01/2019
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2019
1loricrinIBA
01/2019
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Insulin ReceptorIBA
01/2019
1Differentiation AntigensIBA
01/2019
1Threonine (L-Threonine)FDA Link
01/2018
1AutoantibodiesIBA
01/2018
1Type II Keratins (Type II Keratin)IBA
01/2018
1Desmoglein 2IBA
08/2015
1Connexin 43 (Connexin43)IBA
08/2015
1PlectinIBA
06/2015
1Small Interfering RNA (siRNA)IBA
05/2014
1Protein Kinases (Protein Kinase)IBA
05/2014
1enzastaurinIBA
05/2014
1Cre recombinaseIBA
01/2013
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
11/2012
1Desmoplakins (Desmoplakin)IBA
10/2012
1EnzymesIBA
06/2012
1BilirubinIBA
06/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
1CollagenIBA
09/2009
1UbiquitinIBA
11/2008
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2008
1Amino AcidsFDA Link
05/2006
1DNA (Deoxyribonucleic Acid)IBA
05/2006
1Dichlorodiphenyldichloroethane (DDD)IBA
03/2006
1Bisbenzimidazole (Hoechst 33258)IBA
12/2005
1Keratin-18 (Keratin 18)IBA
03/2005
1Acetates (Acetic Acid Esters)FDA Link
11/2004
1anthraceneIBA
11/2004
1Keratin-10IBA
11/2004

Therapy/Procedure

4Therapeutics
12/2022 - 03/2009
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2009
1Intradermal Injections
09/2009